Treatment with relacorilant plus Abraxane (nab-paclitaxel) may offer a broader option for patients with platinum-resistant ...

A major update appears in the Boxed Warning, the most prominent safety warning required by the FDA. The warning now ...

Dr. Suneel Kamath, a gastrointestinal medical oncologist at Cleveland Clinic in Ohio and an assistant professor of medicine ...

Ongoing monitoring remains a cornerstone of survivorship care for patients with cancer, helping detect recurrence early and ...

Sabari recommends regular activity, such as walking 30 minutes a day several times a week, to help maintain lung strength.

Nocturnal symptoms and musculoskeletal pain are filtered through relapse fear, driving repetitive interpretation of ...

Moving gemcitabine/nab-paclitaxel to every-other-week dosing decreases infusion visits and may lessen cumulative toxicity, ...

The DURIPANC study evaluates Ampligen, an immune system modulator, in combination with Imfinzi, a PD-L1 immune checkpoint ...

The investigational oral therapy KTX-1001, also known as gintemetostat, is catching interest as a potential treatment for a subgroup of patients with multiple myeloma, as an expert explained in a ...

Post-diagnosis risk assessment clarifies cancer etiology and germline contribution, shaping therapeutic planning, prevention ...

World Cancer Day serves as a powerful reminder of the global impact of cancer and the shared responsibility to address it. In ...

World Cancer Day highlights the shared impact of cancer and the importance of staying engaged and connected across the cancer ...